Completed NA INTERVENTIONAL 1-arm NCT05855486

PMCF Study to Evaluate Performance and Safety of LUXIDROPIN BABY & JUNIOR

An Interventional, Non-comparative, Single-center Post Marketing Clinical Follow-up (PMCF) Study to Evaluate Performance and Safety of LUXIDROPIN BABY & JUNIOR Used to Facilitate the Removal of Ocular Secretions in Pediatric Subjects

Sponsor: C.O.C. Farmaceutici S.r.l.

Conditions Ocular Discharge

Interventions Saline eye drops

Updated 3 times since 2023 Last updated: May 3, 2023 Started: Oct 12, 2022 Primary completion: Mar 23, 2023 Completion: Mar 23, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05855486, this NA trial focuses on Ocular Discharge and remains completed. Sponsored by C.O.C. Farmaceutici S.r.l., it has been updated 3 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jun 2023 — Jul 2024 [monthly]

Completed NA

First recorded

Oct 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

C.O.C. Farmaceutici S.r.l.

Data source: C.O.C. Farmaceutici S.r.l.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Catanzaro, Italy